- Previous Close
192.80 - Open
194.20 - Bid 197.80 x --
- Ask 198.40 x --
- Day's Range
194.20 - 200.00 - 52 Week Range
129.20 - 206.50 - Volume
103,119 - Avg. Volume
50,048 - Market Cap (intraday)
29.818B - Beta (5Y Monthly) 1.46
- PE Ratio (TTM)
132.40 - EPS (TTM)
1.50 - Earnings Date Feb 7, 2025 - Feb 11, 2025
- Forward Dividend & Yield 1.40 (0.73%)
- Ex-Dividend Date Apr 29, 2024
- 1y Target Est
216.01
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company's Healthcare services includes service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness services; hospital care; and preventive care. Its Diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate, individuals, and public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.
www.medicover.com45,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: MCOV-B.ST
View MorePerformance Overview: MCOV-B.ST
Trailing total returns as of 1/15/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MCOV-B.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MCOV-B.ST
View MoreValuation Measures
Market Cap
28.95B
Enterprise Value
41.22B
Trailing P/E
127.74
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.26
Price/Book (mrq)
5.03
Enterprise Value/Revenue
1.79
Enterprise Value/EBITDA
12.32
Financial Highlights
Profitability and Income Statement
Profit Margin
0.99%
Return on Assets (ttm)
2.65%
Return on Equity (ttm)
3.08%
Revenue (ttm)
2B
Net Income Avi to Common (ttm)
19.7M
Diluted EPS (ttm)
1.50
Balance Sheet and Cash Flow
Total Cash (mrq)
77.2M
Total Debt/Equity (mrq)
216.97%
Levered Free Cash Flow (ttm)
60.69M